In today's Pharma Pulse, the FDA grants a 54-day fast-track approval for high-dose Wegovy under a new priority program while ...

In today's Pharma Pulse, the FDA approves Icotyde as the first targeted oral peptide therapy for moderate-to-severe plaque ...

PharmaKonnect and co-founder of Tina’s Warriors, discusses the biggest post therapy launch patient support gaps.

As manufacturers and stakeholders work to streamline patient access at therapy launch, a critical gap often persists in the sustained support patients require over time. In the fi ...

Cold Chain Technologies (CCT) has announced the upcoming launch of MedAssure, a new cold chain orchestration platform. The platform will be officially introduced at LogiPharma 2026, where the company ...

Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into their commercialization plans. At this year’s Access USA conference, ...

Brok Vandersteen, VP of Business Development, AssistRX, explains how policy pressures push life sciences companies toward direct-to-patient model adoption. At this year’s Access USA conference, ...

VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into their commercialization plans.

In today’s Pharma Pulse, the FDA expands a key biologic approval for pediatric patients, and new research highlights the success of pharmacist-led testing in rural communities. Welcome to Pharma Pulse ...

A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...

This insight piece explores how treatment patterns in bladder cancer have shifted as immunotherapy options have expanded in community oncology. You’ll learn how combination regimens such as enfortumab ...